Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

ZEROHour July 2021 Issue




ASCO Webinar Highlights – New Developments in Prostate Cancer

New Developments in Prostate Cancer Webinar

On Wednesday, June 30th, Dr. Tomasz Beer, Professor of Medicine at Oregon Health & Sciences University and ZERO Medical Advisory Board Member, joined the ZERO community to share an in-depth update on research, diagnosis, and treatment advances in prostate cancer from the 2021 annual American Society of Clinical Oncology (ASCO) meeting. Webinar attendees heard preliminary trial results from several clinical trials currently underway and learned about trial recruitment, adverse events (side effects), and groundbreaking advances in cancer early detection.

Replay the Webinar

Help us understand appetite loss and advanced cancer

Help us understand a potential treatment for loss of appetite in people with advanced cancer

Introducing a research study for loss of appetite in people with advanced cancer

Many people with advanced cancer struggle with low appetite levels and the weight loss that comes with it. That’s why we are researching a study drug — to understand its effect on appetite in people who are experiencing loss of appetite, unintentional weight loss, weakness, and fatigue caused by advanced cancer.

We are looking for people who:

  • Are at least 18 years old
  • Are living with advanced prostate, nonsmall cell lung, pancreatic, colorectal, breast, or ovarian cancer

You will also need to meet a few other requirements in order to take part.

If you or someone you know may be interested in our study, please visit our site to learn more about taking part.

Learn More

(This content is brought to you by Pfizer Inc.)

Symposium Wrap Up/Highlights

Racial Disparities Symposium

Last month, ZERO hosted its inaugural Racial Disparities in Prostate Cancer Symposium. During this half-day educational event, attendees from around the country had the opportunity to learn about disparities that exist between Black men and other men in prostate cancer incidence, treatment, and outcomes. These disparities are well-documented in research and literature and ZERO is working with our Racial Disparities Task Force on a variety of measures and interventions to help improve outcomes for men and families at the highest risk. In case you missed it, here are the session videos.

In addition, a newly launched microsite is now available discussing the racial disparities that exist in prostate cancer. This includes five separate pages of information, links to peer-reviewed published literature, and patient resources that men and their families at the highest risk can utilize to help make their prostate cancer journeys less difficult. Please visit www.zerocancer.org/disparities to learn more! A huge thank you to our sponsors, Janssen, Pfizer and AstraZeneca, for their support of the creation and launch of this new content and mini-site.

Visit the New Website

Share Your Story

Share Your Story

The journey to end prostate cancer doesn’t happen alone. Share your prostate cancer story with ZERO. Whether you are a current patient, survivor, family member, caregiver, volunteer, etc., we want to hear about your experience and share your courage and strength with the ZERO community. Help inspire others by sharing your journey to ZERO.

Share Your Story

Veteran’s Webinar

Upcoming Veterans Webinar

Veterans are a high-risk population for prostate cancer, with an incidence rate that is twice that of the general population. It is critical that we protect our protectors. Join this educational webinar and hear from Dr. Minhaj Siddiqui about your risk for prostate cancer and what you should know about your treatment options. Veteran prostate cancer patient, Chris Provan, will share his story about how the key to his successful treatment was taking advantage of decision making tools and support resources. We’ll be joined by a VA representative who will offer tips and insight into how you can access care within the Veterans Health Administration, or in your community. We’ll also have a special appearance by an elected official who will tell you what new policy changes might affect your prostate cancer care soon. Visit our website to learn more about this free online event, or to register.

Register Now

PCRP Consumer Reviewers Needed

The Prostate Cancer Research Program (PCRP) is seeking prostate cancer survivors and patients to participate in the review of biomedical research applications. Since 1997, the PCRP has been dedicated to supporting research focused on eradicating prostate cancer, and specifically seeks to promote highly innovative, groundbreaking research, high-impact research with near-term clinical relevance and the next generation of prostate cancer investigators through mentored research.

Participants in this program will act as subject matter experts on prostate cancer bringing their experience and perspective to the evaluation of research grant applications. All work is conducted electronically and will be over a 6 to 8 week period. Your work will culminate in a 1 to 2 day virtual meeting. For more information, please contact Ali Manson, Vice President, Government Relations & Advocacy.

Learn More

Upcoming Webinars

Upcoming Prostate Cancer Webinars

Us TOO is proud to offer the next installment of their 2021 webinar series: What is Right for Me in My Prostate Cancer Treatment?

Join Thursday, July 29, 7:00 – 8:30 PM Central time.

» Register for the free webinar here

Champions Corner

Kris and Michael Rangel

Honoring Her Husband

Kris Rangel, from San Antonio, TX, found ZERO in 2018 after her husband Michael was diagnosed with prostate cancer. That year they attended the San Antonio, Dallas/Fort Worth, and Corpus Christi Run/Walk events. Unfortunately, in 2019 at the young age of 44, Michael lost his battle to prostate cancer. Kris has made it her mission to raise awareness so other families don’t have to experience what they went through. In March 2021, Kris attended her first ZERO Summit and is in the process of becoming a Caregiver Mentor.
» Apply to be a Champion Like Kris

Clinical Trials

patient photo

Clinical Trials

Clinical trials are a great way for prostate cancer patients to help in the fight against cancer. Our partners at Bristol Myers Squibb are currently enrolling advanced prostate cancer patients in clinical trial studies now.
» Sign up today
(This content is provided in partnership with Bristol Myers Squibb.)

Grow & Give

Grow and Give

Grow & Give Sign Ups are Open!

The hairiest time of the year is almost here! Join in on the facial hair growing fun. Raise funds and awareness to end prostate cancer through Grow & Give with ZERO this November!
» Register Here


patient photo

Know Your PSMA

A rise in your prostate-specific antigen (PSA) level can tell you if your metastatic prostate cancer is progressing. Prostate-specific membrane antigen, or PSMA, can tell you so much more. Once your cancer has spread to other parts of your body, PSA should not be the only biomarker you check.
» Learn More About PSMA
(This content is provided in partnership with AAA/Novartis.128585 | 6/21 )


NYC Marathon

New York Marathon Registrations

ZERO still has slots available as a Charity Partner for the 2021 TCS NYC Marathon! If you or someone you know is interested in participating in the marathon on Sunday, November 7, 2021, please register through our organization. Please know that all of our athletes are responsible for fundraising a mandatory $3,000 for participation in the event. Athletes who do not meet this requirement are responsible for paying the remainder of the fundraising requirement.
» Register for the New York Marathon

Clinical Trials

Patient image

Prostate Cancer Research Study

The TALAPRO-2 clinical trial is enrolling men with metastatic castration-resistant prostate cancer to study a potential treatment. More information is available.
» Learn more
(This content is provided in partnership with Pfizer Oncology.)

Make sure you keep getting emails from ZERO. Add info@zerocancer.org to your address book or safe-sender list.


515 King Street
Suite 420
Alexandria, VA 22314

view this email online

privacy policy

email preferences



This email was intended for


© 2021 ZERO – The End of Prostate Cancer. All rights reserved. ZERO is a 501(c)(3) non-profit organization.